History and development trend of minimally invasive surgical treatment for obesity and diabetes in China.
- Author:
Dan DING
;
Chengzhu ZHENG
1
Author Information
1. Department of Gastrointestinal Surgery, Changhai Hospital, the Second Military Medical University, Shanghai 200433, China. fredzhengzz@ hotmail.com.
- Publication Type:Journal Article
- MeSH:
Bariatric Surgery;
methods;
China;
Diabetes Mellitus, Type 2;
Gastrectomy;
Gastric Bypass;
Humans;
Laparoscopy;
Obesity;
surgery;
Obesity, Morbid;
Weight Loss
- From:
Chinese Journal of Gastrointestinal Surgery
2016;19(8):854-856
- CountryChina
- Language:Chinese
-
Abstract:
Obesity and type 2 diabetes mellitus have already become one of the most serious society-facing problems. Since the first report in the 1950s, gastrointestinal surgery has greatly developed as the golden standard in obesity treatment. With the convincing research and evidence, it is found that gastrointestinal surgery not only can cause weight loss, but can relieve, even cure many metabolic diseases associated with obesity, especially for type 2 diabetes mellitus. The operational manners, including adjustable gastric banding, Roux-en-Y gastric bypass, mini gastric bypass, sleeve gastrectomy, etc., are proved to be safe and effective in treating obesity and type 2 diabetes mellitus, and all of these operations can be performed with laparoscopy. Currently, gastrointestinal surgeons are focusing on the operation treatment for type 2 diabetes mellitus, and more and more gastrointestinal operations are applied in many medical centers in China. However, there are a lot of details that need to be standardized. It is believed, with the evolution of surgical technique, standardization of diagnosis and treatment, and breakthrough in the basic research, the metabolic surgery will get more development in the future.
